Board member Donald Berwick receives $150,000 NRC (NRC) stock grant

Rhea-AI Filing Summary

Berwick Donald M reported acquisition or exercise transactions in this Form 4 filing.

NRC HEALTH director Donald M. Berwick received an equity grant as part of his annual board compensation. He was awarded 7,697 shares of common stock at a price of $0.00 per share, bringing his directly held stake to 7,697 shares after the transaction.

The footnote explains this represents $150,000 of annual equity compensation in the form of restricted stock units under the company’s 2025 Omnibus Incentive Plan, calculated using the closing price before the 2026 annual stockholders’ meeting. The award will vest on the date of the 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination provisions.

Insider Trade Summary

Net Buyer: 7,697 shares

Net Buy 1 txn

Insider Berwick Donald M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,697	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,697 shares (Direct)

Footnotes (1)

1. F1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Key Figures

RSU grant size: 7,697 shares Grant price per share: $0.00 per share Equity compensation value: $150,000 +2 more

5 metrics

RSU grant size 7,697 shares Common stock award on 2026-06-23

Grant price per share $0.00 per share Reported transaction price for equity award

Equity compensation value $150,000 Annual director equity compensation used to size RSU grant

Shares after transaction 7,697 shares Total NRC HEALTH common shares directly held by Berwick

Vesting date reference 2027 annual stockholder meeting Restricted stock units vest on this meeting date

Key Terms

restricted stock units, 2025 Omnibus Incentive Plan, annual equity compensation, vesting, forfeiture, and termination provisions

4 terms

restricted stock units financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Incentive Plan financial

"under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

annual equity compensation financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units"

vesting, forfeiture, and termination provisions financial

"subject to vesting, forfeiture, and termination provisions."

FAQ

What did NRC (NRC) director Donald M. Berwick report in this Form 4?

Donald M. Berwick reported receiving an equity grant of NRC HEALTH common stock. He was awarded 7,697 shares at $0.00 per share as annual director compensation, leaving him with 7,697 directly held shares after the grant.

How large is Donald M. Berwick’s new NRC (NRC) stock award?

The reported award is 7,697 shares of NRC HEALTH common stock. A footnote states this grant equals $150,000 of annual equity compensation, calculated by dividing $150,000 by the closing share price before the 2026 annual stockholder meeting.

What type of compensation is Donald M. Berwick receiving from NRC (NRC)?

Berwick is receiving equity compensation in the form of restricted stock units. The award is part of his annual director compensation, granted under NRC HEALTH’s 2025 Omnibus Incentive Plan and valued at $150,000 based on the stock price before the 2026 annual meeting.

When do Donald M. Berwick’s new NRC (NRC) restricted stock units vest?

The award will vest on the date of NRC HEALTH’s 2027 annual stockholder meeting. Vesting is subject to standard provisions, including vesting, forfeiture, and termination terms specified under the 2025 Omnibus Incentive Plan for directors.

How many NRC (NRC) shares does Donald M. Berwick hold after this transaction?

After the reported grant, Berwick directly holds 7,697 shares of common stock. The Form 4 shows total shares following the transaction equal to 7,697, reflecting his updated direct ownership position at NRC HEALTH.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 04:45 PM Accepted by SEC EDGAR 06/25/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berwick Donald M

(Last) (First) (Middle)

C/O NRC HEALTH

1245 Q STREET

(Street)

LINCOLN NEBRASKA 68508

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NRC HEALTH [ NRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2026		A		7,697(1)	A(1)	$0	7,697	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

	/s/ Donald M. Berwick, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)